Inhibiting B7-H3 expression in NSCLC cell lines has resulted in a marked decrease in the migratory and invasive capabilities of cancer cells, indicating that B7-H3 may facilitate NSCLC progression not only through immune-related mechanisms but also via the upregulation of proteins associated with integrins [125]. This evidence concerns the gene CD276 and cancer.